Gen Digital Inc (GEN) concluded trading on Wednesday at a closing price of $27.84, with 8.76 million shares of worth about $243.85 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -1.52% during that period and on May 07, 2025 the price saw a gain of about 8.24%. Currently the company’s common shares owned by public are about 616.30M shares, out of which, 558.04M shares are available for trading.
Stock saw a price change of 7.61% in past 5 days and over the past one month there was a price change of 17.42%. Year-to-date (YTD), GEN shares are showing a performance of 1.68% which increased to 38.99% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $19.66 but also hit the highest price of $31.72 during that period. The average intraday trading volume for Gen Digital Inc shares is 4.05 million. The stock is currently trading 10.72% above its 20-day simple moving average (SMA20), while that difference is up 6.27% for SMA50 and it goes to 2.55% higher than SMA200.
Gen Digital Inc (NASDAQ: GEN) currently have 616.30M outstanding shares and institutions hold larger chunk of about 83.14% of that.
The stock has a current market capitalization of $17.16B and its 3Y-monthly beta is at 0.99. PE ratio of stock for trailing 12 months is 26.96, while it has posted earnings per share of $1.03 in the same period. Its PEG reads 2.07 and has Quick Ratio of 0.35 while making debt-to-equity ratio of 3.64. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for GEN, volatility over the week remained 3.32% while standing at 3.44% over the month.
Stock’s fiscal year EPS is expected to rise by 11.29% while it is estimated to increase by 11.86% in next year. EPS is likely to grow at an annualized rate of 13.01% for next 5-years, compared to annual growth of 2.87% made by the stock over the past 5-years.
Coverage by UBS stated Gen Digital Inc (GEN) stock as a Buy in their note to investors on December 04, 2024, suggesting a price target of $36 for the stock. On October 24, 2024, Wells Fargo Initiated their recommendations, while on June 07, 2024, Morgan Stanley Downgrade their ratings for the stock with a price target of $27. Stock get an Equal weight rating from Barclays on April 11, 2024.
